Clinical trial
Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients…
NCT00068445 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00068445 |
|---|---|
| Title | Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer |
| Official title | The Efficacy of Lamotrigine in the Management of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double Blind, Placebo-Controlled Trial |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | lamotrigine, Placebo |
| Enrollment | 131 |
| Start date | Feb 1, 2004 |
| Primary completion | May 1, 2006 |
| Completion | Nov 1, 2013 |
| First posted | Sep 11, 2003 |
| Last update posted | May 4, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: